SCHEMBL9542846

SCHEMBL9542846

COc1ccc(CN2C(=O)NC(C#C[Si](C)(C)C)(C3CC3)c3cc(Cl)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 6/20 0.43
SCN9A Q15858 3/20 0.42
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
CMA1 P23946 1/20 0.37
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
PDE1C Q14123 1/20 0.37
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36
OPRL1 P41146 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9571243 0.90 PTGDR2 (0.42) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9571197 0.87 PTGDR2 (0.43) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9144120 0.87 PTGDR2 (0.46) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9571203 0.85 PTGDR2 (0.46) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9280955 0.85 SCN9A (0.42) PTGDR2SCN9AALDH1A1L3MBTL1ADAMTS5
SCHEMBL9540119 0.82 PTGDR2 (0.41) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9571205 0.82 PTGDR2 (0.38) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9541552 0.81 PTGDR2 (0.49) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL27527527 0.80 POLB (0.38) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9571211 0.80 P2RX3 (0.37) PTGDR2SCN9AOPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed